Federated Hermes Inc. lifted its holdings in shares of The Clorox Company (NYSE:CLX - Free Report) by 113.7% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 292,050 shares of the company's stock after acquiring an additional 155,383 shares during the period. Federated Hermes Inc. owned approximately 0.24% of Clorox worth $47,432,000 as of its most recent filing with the SEC.
A number of other hedge funds have also modified their holdings of the stock. Brooklyn Investment Group boosted its stake in shares of Clorox by 163.8% in the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company's stock valued at $25,000 after purchasing an additional 95 shares in the last quarter. Continuum Advisory LLC increased its holdings in shares of Clorox by 300.0% during the third quarter. Continuum Advisory LLC now owns 184 shares of the company's stock worth $30,000 after buying an additional 138 shares in the last quarter. Millstone Evans Group LLC bought a new position in shares of Clorox in the fourth quarter valued at approximately $31,000. Asset Planning Inc bought a new stake in Clorox during the 4th quarter worth approximately $32,000. Finally, Halbert Hargrove Global Advisors LLC acquired a new stake in Clorox during the 4th quarter valued at $36,000. 78.53% of the stock is owned by institutional investors and hedge funds.
Clorox Trading Up 0.3 %
Shares of CLX traded up $0.45 during trading hours on Friday, hitting $141.35. The company had a trading volume of 1,249,590 shares, compared to its average volume of 1,298,188. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $171.37. The stock's 50 day moving average price is $147.39 and its 200 day moving average price is $157.21. The firm has a market cap of $17.41 billion, a P/E ratio of 38.62, a P/E/G ratio of 2.62 and a beta of 0.61.
Clorox (NYSE:CLX - Get Free Report) last posted its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, topping analysts' consensus estimates of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same quarter last year, the company earned $2.16 earnings per share. On average, research analysts predict that The Clorox Company will post 7.15 EPS for the current year.
Clorox Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd will be given a $1.22 dividend. The ex-dividend date is Wednesday, April 23rd. This represents a $4.88 annualized dividend and a dividend yield of 3.45%. Clorox's dividend payout ratio is 133.33%.
Analyst Upgrades and Downgrades
CLX has been the topic of several research reports. JPMorgan Chase & Co. cut their price target on Clorox from $173.00 to $151.00 and set a "neutral" rating on the stock in a research note on Friday. StockNews.com downgraded shares of Clorox from a "buy" rating to a "hold" rating in a research note on Sunday, January 5th. Evercore ISI raised their target price on shares of Clorox from $145.00 to $155.00 in a research note on Tuesday, February 4th. DA Davidson lowered their price objective on Clorox from $171.00 to $169.00 and set a "neutral" rating on the stock in a research report on Wednesday, February 5th. Finally, Wells Fargo & Company reduced their price target on Clorox from $161.00 to $155.00 and set an "equal weight" rating on the stock in a research report on Wednesday, April 2nd. Three analysts have rated the stock with a sell rating, ten have given a hold rating and one has issued a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average price target of $156.75.
Get Our Latest Analysis on CLX
Clorox Profile
(
Free Report)
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Read More

Before you consider Clorox, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.
While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.